Calliditas Therapeutics
CALT
#5406
Rank
$1.09 B
Marketcap
$40.00
Share price
-0.10%
Change (1 day)
113.90%
Change (1 year)

Revenue for Calliditas Therapeutics (CALT)

Revenue in 2024 (TTM): $0.15 Billion USD

According to Calliditas Therapeutics's latest financial reports the company's current revenue (TTM ) is $0.15 Billion USD. In 2023 the company made a revenue of $0.11 Billion USD an increase over the revenue in the year 2022 that were of $76.26 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Calliditas Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) $0.15 B32.46%
2023 $0.11 B50.93%
2022 $76.26 M193.52%
2021 $25.98 M26931.42%
2020 $0.09 M-99.52%
2019 $19.86 M
2018 N/A
2017 N/A